Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Treatment With VEGF Inhibitors May Cause Renal Thrombotic Microangiopathy
Link ID 3981
Title Treatment With VEGF Inhibitors May Cause Renal Thrombotic Microangiopathy
Url http://www.medscape.com/viewarticle/571338?src=rss
Description VEGF inhibitors, such as bevacizumab, may cause glomerular disease that is characteristic of thrombotic microangiopathy. Medscape Medical News
Category Articles > Hematology-Oncology
Keywords
Date Mar 13, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Hematology-Oncology
1. Can a Surgical Safety Checklist Reduce Postoperative Complications?
  Commentary on a study on the effect of a surgical safety checklist on surgical outcomes, published January 2009 in the New England Journal of Medicine. Medscape General Surgery
Category:   Articles > Hematology-Oncology


2. Concurrent Breast Stroma Sarcoma and Breast Carcinoma
  A presentation with bilateral breast cancer is uncommon, but rarer still is for bilateral cancers to be two completely distinct histological types. Journal of Medical Case Reports
Category:   Articles > Hematology-Oncology


3. Colorectal Cancer Screening in U.S. Continues to IncreaseColorectal Cancer Screening in U.S. Continu
  New gains since 2008. br / iMedscape Medical News/i
Category:   Articles > Hematology-Oncology


4. Bisphosphonates for Osteoporosis Reduce Risk for Breast Cancer
  Two retrospective studies suggesting that postmenopausal women who take oral bisphosphonates for osteoporosis have a reduced risk for breast cancer have now been published. Medscape Medical News
Category:   Articles > Hematology-Oncology


5. Optimizing Adjuvant Treatment for High-Risk Early Breast Cancer: An Expert Interview With Dr. Cliffo
  In this Expert Interview from SABCS 2007, Dr. Clifford Hudis comments about adjuvant chemotherapy in breast cancer, with particular emphasis on when and for whom treatment should be offered.
Medscape Hematology-Oncology
Category:   Articles > Hematology-Oncology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS